News

Microline Pentax, a wholly owned subsidiary of Hoya and a manufacturer of reposable instruments for minimally invasive surgery, has acquired Starion Instruments, a developer of surgical technology for

The lawsuit contends that Davol’s recently released Sorbafix device infringes multiple claims of Covidien’s US patent. The patent generally relates to a system for controllably discharging fasteners from

These findings provide further evidence of mTOR as a validated cancer target with potential clinical applicability in several different tumor types, said Ariad. Deforolimus demonstrated potent single-agent, antitumor

The studies presented by the company further explore the detailed mechanism of action of LOR-253. The key findings include MTF-1 dependent induction of a novel tumor suppressor, namely

First Quarter 2009: Gross margin was 50.1% versus 65.4% in the first quarter of 2008 Operating expenses were $13.1 million versus $13.2 million in the same period in

Gross Profit Gross margin (52.0%) was higher than 2007 (50.9%) as expected, gaining from foreign currency effects and economies of scale as Afinion and AxSYM sales volumes have

Procedure minimums for “fee per use” revenue are part of the agreement. “Misonix is pleased to partner with DTL Medical to provide prostate HIFU to hospitals in Romania

Among the several advancements announced in 2008 was the introduction on Oncentra Brachy, a new volume-based treatment planning solution that optimizes cancer treatment planning with brachytherapy. Additionally, Oncentra

Motorika will also use the funds to increase its clinical program and awareness of its product line while working with its key customers and partners to further enhance